Literature DB >> 35120864

A successful intervention to improve medication adherence in Black patients with hypertension: Mediation analysis of 28-site TEAM trial.

Bonnie L Svarstad, Roger L Brown, Theresa I Shireman.   

Abstract

BACKGROUND: We previously reported the main effects and cost-effectiveness of a successful multifaceted Team Education and Adherence Monitoring (TEAM) intervention to improve refill adherence in Black patients with hypertension. It is important to identify the key mediators or intervention components that contributed to this intervention effect.
OBJECTIVES: This study aimed to conduct a "mediation analysis" to determine which intervention components had the largest effect on refill adherence and assess patient satisfaction with pharmacy care.
METHODS: A cluster-randomized trial was conducted among 576 Black patients in 28 pharmacies (14 TEAM, 14 control). TEAM participants were invited to 6 visits with a pharmacist-technician team that monitored the patient's blood pressure and used a 9-item Brief Medication Questionnaire, Brief Goal Check, and other novel tools to identify and reduce barriers to adherence in Black patients. Control participants received printed information only. Refill adherence was defined as >80% days covered (proportion of days covered) per refill records during months 7 to 12 (postintervention); potential mediators and patient satisfaction were assessed using a research questionnaire administered at month 6. A structural probit model examined 4 potential mediators that might explain intervention success.
RESULTS: Of 4 potential mediators, the most important factors in explaining the improvement in refill adherence (postintervention) were greater pharmacist collaboration with patient in barrier reduction (68.5% of total indirect effect) and patient use of a pillbox (27.2% of total indirect effect). Pharmacist contact with physician and suggestion of a change in regimen did not have significant effects on adherence. TEAM participants were more likely than control participants to rate their pharmacist care as "very satisfactory" (80.2% vs. 44.2%, P < 0.001) and technician care as "very satisfactory" (81.2% vs. 47.4%, P < 0.001).
CONCLUSION: Refill adherence and satisfaction can be improved in Black patients with hypertension by implementing a collaborative TEAM model with novel tools that enable community pharmacists and technicians to help identify and reduce the core barriers to adherence. Our results can be used to individualize and improve patient care and adherence outcomes in this vulnerable population.
Copyright © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35120864      PMCID: PMC9090964          DOI: 10.1016/j.japh.2022.01.002

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  19 in total

Review 1.  Interventions promoting adherence to cardiovascular medicines.

Authors:  Judith van Dalem; Ines Krass; Parisa Aslani
Journal:  Int J Clin Pharm       Date:  2012-01-24

2.  Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.

Authors:  Gabriel S Tajeu; Shia T Kent; Ian M Kronish; Lei Huang; Marie Krousel-Wood; Adam P Bress; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.

Authors:  Matthew Ritchey; Anping Chang; Christopher Powers; Fleetwood Loustalot; Linda Schieb; Michelle Ketcham; Jeffrey Durthaler; Yuling Hong
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-09-16       Impact factor: 17.586

4.  Ethnic differences in temporal orientation and its implications for hypertension management.

Authors:  C M Brown; R Segal
Journal:  J Health Soc Behav       Date:  1996-12

Review 5.  Implicit Racial/Ethnic Bias Among Health Care Professionals and Its Influence on Health Care Outcomes: A Systematic Review.

Authors:  William J Hall; Mimi V Chapman; Kent M Lee; Yesenia M Merino; Tainayah W Thomas; B Keith Payne; Eugenia Eng; Steven H Day; Tamera Coyne-Beasley
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

6.  Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a systematic review.

Authors:  Aleksandra Milosavljevic; Trudi Aspden; Jeff Harrison
Journal:  Int J Pharm Pract       Date:  2018-06-21

7.  Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study.

Authors:  Ivy Poon; Lincy S Lal; Marvella E Ford; Ursula K Braun
Journal:  Ann Pharmacother       Date:  2009-02-03       Impact factor: 3.154

8.  The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.

Authors:  Bonnie L Svarstad; Jane Morley Kotchen; Theresa I Shireman; Stephanie Y Crawford; Pamela A Palmer; Eva M Vivian; Roger L Brown
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-05

9.  Racial and ethnic disparities in medication adherence among privately insured patients in the United States.

Authors:  Zhiwen Xie; Patricia St Clair; Dana P Goldman; Geoffrey Joyce
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

Review 10.  Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.

Authors:  Keith C Ferdinand; Kapil Yadav; Samar A Nasser; Helene D Clayton-Jeter; John Lewin; Dennis R Cryer; Fortunato Fred Senatore
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.